60 Degrees Pharmaceuticals Warrant
SXTPW
8 hedge funds and large institutions have $43.9K invested in 60 Degrees Pharmaceuticals Warrant in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.5% less ownership
Funds ownership: 6.79% → 6.29% (-0.5%)
22% less capital invested
Capital invested by funds: $56.3K → $43.9K (-$12.4K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$417 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.41K |
| 2 |
VF
Virtu Financial
New York
|
-$1K |
| 3 |
CS
Clear Street
New York
|
-$38 |
SXTPW Hedge Fund Activity: Q3 2024 in Review
8 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals Warrant (SXTPW) for Q3 2024, worth a combined $43.9K — down 22% from $56.3K a quarter earlier.
Fund positioning in SXTPW was balanced in Q3 2024: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $417. The largest seller was Sabby Management, cutting an estimated $1.41K.
- 8 institutional investors held 60 Degrees Pharmaceuticals Warrant (SXTPW) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $43.9K of 60 Degrees Pharmaceuticals Warrant stock for Q3 2024, down 22% quarter-over-quarter.
- 1 fund opened new 60 Degrees Pharmaceuticals Warrant positions in Q3 2024 and 1 closed out, a net change of 0 holders.
- The largest 60 Degrees Pharmaceuticals Warrant buyer in Q3 2024 was Citadel Advisors, an estimated $417 added.
- The largest 60 Degrees Pharmaceuticals Warrant seller in Q3 2024 was Sabby Management, an estimated $1.41K sold.
Based on aggregated 13F filings for Q3 2024.